Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas. | Nat Commun | 2022 | 36443313 | PubTator, text mining | PubMed |
| Molecular mechanism and potential therapeutic targets of liver metastasis from gastric cancer. | Front Oncol | 2022 | 36439439 | PubTator, text mining | PubMed |
| AJUBA and WTIP can compete with LIMD1 for junctional localization and LATS regulation. | MicroPubl Biol | 2022 | 36439396 | PubTator, text mining | PubMed |
| Editorial: The self-renewal and reprogramming of cancer stem cells and their crosstalk with the immune microenvironment. | Front Cell Dev Biol | 2022 | 36438558 | PubTator, text mining | PubMed |
| Insights into protein post-translational modification landscapes of individual human cells by trapped ion mobility time-of-flight mass spectrometry. | Nat Commun | 2022 | 36433961 | PubTator, text mining | PubMed |
| Bcl-2 Family Members Bcl-xL and Bax Cooperatively Contribute to Bortezomib Resistance in Mantle Cell Lymphoma. | Int J Mol Sci | 2022 | 36430955 | PubTator, text mining | PubMed |
| Coordination of AMPK and YAP by Spatholobi Caulis and Procyanidin B2 Provides Antioxidant Effects In Vitro and In Vivo. | Int J Mol Sci | 2022 | 36430207 | PubTator, text mining | PubMed |
| Crosstalk between the Hippo Pathway and the Wnt Pathway in Huntington's Disease and Other Neurodegenerative Disorders. | Cells | 2022 | 36429058 | PubTator, text mining | PubMed |
| Circulating Long Non-Coding RNAs Could Be the Potential Prognostic Biomarker for Liquid Biopsy for the Clinical Management of Oral Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 36428681 | PubTator, text mining | PubMed |
| DNMT3B and TET1 mediated DNA methylation of LATS1 regulates BC progression via hippo signaling pathway. | Pathol Res Pract | 2022 | 36413827 | PubTator, text mining | PubMed |
| The therapeutic potential of natural products for treating pancreatic cancer. | Front Pharmacol | 2022 | 36408249 | PubTator, text mining | PubMed |
| Effect of Inactivation of Mst1 and Mst2 in the Mouse Adrenal Cortex. | J Endocr Soc | 2022 | 36405866 | PubTator, text mining | PubMed |
| Suppression of YAP safeguards human naïve pluripotency. | Development | 2022 | 36398796 | PubTator, text mining | PubMed |
| Bone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects. | Front Immunol | 2022 | 36389844 | PubTator, text mining | PubMed |
| Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets. | Front Immunol | 2022 | 36389798 | PubTator, text mining | PubMed |
| Circular RNAs as diagnostic biomarkers for gastric cancer: A comprehensive update from emerging functions to clinical significances. | Front Genet | 2022 | 36386850 | PubTator, text mining | PubMed |
| The Regulation of the Hippo Pathway by Intercellular Junction Proteins. | Life (Basel) | 2022 | 36362947 | PubTator, text mining | PubMed |
| Targeted Disruption of Lats1 and Lats2 in Mice Impairs Testis Development and Alters Somatic Cell Fate. | Int J Mol Sci | 2022 | 36362374 | PubTator, text mining | PubMed |
| The Rocky Road from Preclinical Findings to Successful Targeted Therapy in Pleural Mesothelioma. | Int J Mol Sci | 2022 | 36362209 | PubTator, text mining | PubMed |
| Neuromedin S Regulates Steroidogenesis through Maintaining Mitochondrial Morphology and Function via NMUR2 in Goat Ovarian Granulosa Cells. | Int J Mol Sci | 2022 | 36362185 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=31